Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
John Minchillo / AP
Researchers at Massachusetts General Hospital have "developed a drug that mimics sunlight to make the skin tan," BBC reports.
How it works: The drug "tricks the skin into producing the brown form of the pigment melanin" that, in tests on skin samples, blocked harmful UV rays.
Why it matters: Approximately 9,500 people in the U.S. are diagnosed with skin cancer every day, according to the American Academy of Dermatology, making it the most common form of cancer. If proven successful after further testing, the drug could play a key role in preventing skin cancer.
Bonus: The drug may even be able to slow the appearance of aging.